Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Physiologically Based Pharmacokinetic Modeling of Central Nervous System Pharmacokinetics of CDK4/6 Inhibitors to Guide Selection of Drug and Dosing Regimen for Brain Cancer Treatment

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2021Source: DataRank Database

Physiologically Based Pharmacokinetic Modeling of Central Nervous System Pharmacokinetics of CDK4/6 Inhibitors to Guide Selection of Drug and Dosing Regimen for Brain Cancer Treatment is a research paper published in Clinical Pharmacology & Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

Linked data & code

gen nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.75)OA: hybridTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Jun Jiang ORCID,Jianmei Wu,Xun Bao ORCID,Nader Sanai ORCID,Jing Li ORCID

Live enrichment

PubMed:32799335 PMC:PMC7854954 OpenAlex:https://openalex.org/W3049329286

National Institutes of Health

Grant: P30 CA022453

National Institutes of Health

Grant: 3P30CA022453-37S2

Cancer Center Support Grant

FWCI

1.75

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1002/cpt.2021

publisherhttps://doi.org/10.1002/cpt.2021

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt.2021

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2021

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cpt.2021

Fields of Study

Advanced Breast Cancer TherapiesCancer-related cognitive impairment studiesCancer Treatment and Pharmacology0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AminopyridinesAntineoplastic AgentsBenzimidazolesBrainBrain NeoplasmsHumansPiperazinesPurinesPyridinesProtein Kinase InhibitorsCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6

Keywords

PharmacokineticsDosingPharmacologyMedicineRegimenCentral nervous systemDrugInternal medicineBrain NeoplasmsPyridinesResearchAminopyridinesBrainCyclin-Dependent Kinase 4Antineoplastic AgentsCyclin-Dependent Kinase 6PiperazinesPurinesHumansBenzimidazolesProtein Kinase Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Physiologically Based Pharmacokinetic Modeling of Central Nervous System Pharmacokinetics of CDK4/6 Inhibitors to Guide Selection of Drug and Dosing Regimen for Brain Cancer Treatment

FAIR Checklist

Authors (5)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)